NZYM B Novozymes A/S Class B

Transactions under Novonesis’ share buyback program

Transactions under Novonesis’ share buyback program

Please read the announcement in PDF

Attachment



EN
07/04/2025

Underlying

NZYM BNovozymes A/S Class B

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Novozymes A/S Class B

 PRESS RELEASE
Free
NZYM B Novozymes A/S C...

Novonesis delivered a strong Q1 with 11% organic growth and confirms f...

Novonesis delivered a strong Q1 with 11% organic growth and confirms full-year outlook COPENHAGEN, Denmark – May 8, 2025. The global leader in biosolutions, Novonesis, had a strong start to its financial year with organic sales growth of 11% and an adjusted EBITDA margin of 38.3%. The company maintains the full-year outlook. The sales growth was broad-based across both regions and industries. Emerging markets grew by 15% organically, and developed markets increased by 9%. Across all sales areas, the company delivered double-digit growth in the quarter. Ester Baiget, President & CEO, say...

12h / 2m 1 EN
 PRESS RELEASE
Free
NZYM B Novozymes A/S C...

Interim report Q1 2025

Interim report Q1 2025 Strong start to the year and confirmed full-year outlook Ester Baiget, President & CEO:  “We delivered strong sales growth and earnings in the first quarter, with all four sales areas showing double-digit growth. Growth was driven by strong innovation especially in emerging markets, and with a continued broad pull for our solutions in developed markets. Synergies are materializing as expected and we are confirming the full-year outlook. We continue to see solid demand across the business, and our regional presence and resilient global setup enable us to respond with...

12h / 4m 1 EN
 PRESS RELEASE
Free
NZYM B Novozymes A/S C...

Transactions under Novonesis’ share buyback program

Transactions under Novonesis’ share buyback program Please read the announcement in PDF Attachment

May 5, 2025 1 EN
 PRESS RELEASE
Free
NZYM B Novozymes A/S C...

Transactions under Novonesis’ share buyback program

Transactions under Novonesis’ share buyback program Please read the announcement in PDF Attachment

April 28, 2025 1 EN
 PRESS RELEASE
Free
NZYM B Novozymes A/S C...

Andrew Taylor joins Novonesis’ Executive Leadership Team

Andrew Taylor joins Novonesis’ Executive Leadership Team Andrew Taylor will assume the role as EVP of Food & Beverage Biosolutions at Novonesis. Please read the full announcement in PDF. Attachment

April 22, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch